LUNG CANCER RESEARCH FOUNDATION
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$7,529,664
Cash & Equivalents
94%
Receivables (Non-Related)
3%
Prepaid Expenses
2%
Other Assets
1%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$2,703,563
Grants Payable
54%
Deferred Revenue
23%
Payables & Accruals
23%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$5,967,714
$7,092,931
+19%
Receivables (Non-Related)
$733,457
$223,370
-70%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$140,415
$124,646
-11%
Investments
-
-
-
Property, Plant, & Equipment (net)
$0
$0
-
Other Assets
$104,811
$88,717
-15%
Total Assets
$6,946,397
$7,529,664
+8%
Liabilities
2023
2024
Change
Payables & Accruals
$419,291
$619,504
+48%
Grants Payable
$2,423,603
$1,454,059
-40%
Deferred Revenue
$401,269
$630,000
+57%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$66,338
$0
-100%
Total Liabilities
$3,310,501
$2,703,563
-18%
Net assets
2023
2024
Change
Restricted Net Assets
$1,973,271
$660,149
-67%
Unrestricted Net Assets
$1,662,625
$4,165,952
+151%
Net assets
2023
2024
Change
Net assets
+$3,635,896
+$4,826,101
+33%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)